biomarker detection Sep 7, 2022 Isofol Medical Halts Colon Cancer Study After Negative Readout; Continues Subgroup Analyses Aug 8, 2022 NHS Should Offer Genetic Profiling to All Cancer Patients in UK, Experts Say Jul 28, 2022 Turning Point Therapeutics Receives Positive FDA Feedback on Repotrectinib NSCLC Application Jul 28, 2022 Canadian Nurse Navigator-Led Program Aims to Improve Breast Cancer Genomic Test Access Premium Jul 12, 2022 NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling Jun 23, 2022 Novartis Nets Tumor-Agnostic Approval for Tafinlar-Mekinist Combo Jun 21, 2022 Recursion Launches Clinical Trial for Targeted Drug in NF2-Mutated Meningioma Patients Jun 14, 2022 Syapse, Pierian Partner to Advance Precision Oncology at Central Florida Health System Apr 12, 2022 New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia Premium Apr 11, 2022 Adding Genetic Information to PSA Improves Biomarker's Performance in Prostate Cancer Diagnosis Mar 29, 2022 Novartis, Lantheus Partner on PSMA Imaging-Based Patient Selection in Pluvicto Trials Mar 29, 2022 Zentalis Pharmaceuticals, Caris Life Sciences Ink Precision Oncology Partnership Feb 28, 2022 Poor Oncologist-Patient Communication Adding to NSCLC Biomarker Testing Disparities, Survey Finds Premium Feb 24, 2022 Gene Expression Biomarker Panel Shows Prognostic, Predictive Promise for Gastric Cancer Premium Dec 3, 2021 I-Mab Begins Study of Uliledlimab Plus Tecentriq in Advanced Solid Tumors Nov 17, 2021 Geneseeq Multi-Biomarker Approach Predicts EGFR-Mutated NSCLC Patients' Adjuvant Therapy Benefit Premium Oct 21, 2021 LXRepair, Gustave Roussy Ink Research Partnership in Personalized Radiotherapy Sep 30, 2021 Real-World Data from OneOncology, Roche Shed Light on NSCLC NGS Trends in Community Practices Premium Sep 23, 2021 ESMO Oncologists Debate Optimal Timing for Broad NGS, Align on Key Barriers to Precision Oncology Premium Sep 15, 2021 Lung Cancer Biomarker Testing Survey Reveals Access Gaps, Attitudes in Community, Academic Practices Premium Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
